Pallimed Solutions Recalls HCG Vials Due to Sterility Concerns
Pallimed Solutions is recalling 261 vials of compounded HCG Chorionic Gonadotropin nationwide due to FDA inspectional findings regarding sterility assurance.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric. The hazard involves a lack of assurance of sterility, which poses a significant risk of infection or serious injury.
Plain-English summary
Pallimed Solutions Pharmacy in Woburn, Massachusetts, is recalling 261 vials of compounded HCG Chorionic Gonadotropin. The recall is being conducted nationwide for all lots within their expiry dates.
The FDA initiated this recall following inspectional findings that raised concerns about quality control procedures. Specifically, the inspection identified issues that impacted the assurance of sterility for the product.
Consumers who possess these vials should stop using them and contact their healthcare provider or the recalling firm for instructions on disposal or replacement.
The recalled product
- Product
- HCG Chorionic Gonadotropin, compounded by Pallimed Solutions Pharmacy, Woburn, MA
- Manufacturer
- Pallimed Solutions
- Category
- Drug — Compounded Biologic
- Hazard
- Affected units
- 261
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 25 recalled by Pallimed Solutions under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 25 products in this recall →Related recalls
Same manufacturer · Pallimed Solutions
See all →- SeverePallimed Solutions Recalls Atropine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-08-21
- SeverePallimed Solutions Recalls Trimix Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-08-21
- SevereQuadmix Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-08-21
- SeverePallimed Acetylcysteine Ophthalmic Solution Recalled for Sterility Concerns
FDA (Drugs) · 2013-08-21
- SeverePallimed Solutions Recalls Testosterone Injection Due to Sterility Concerns
FDA (Drugs) · 2013-08-21
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29